Speciality Medicines Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 6,000 shares,. Its Average Traded Price (ATP) is ₹154.62, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1000 @ ₹154.85.
Speciality Medicines has an upper circuit limit of ₹170.35 and a lower circuit limit of ₹139.45. The total value traded stands at ₹9.28 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1000. Speciality Medicines also offers a dividend yield of 0%.
Speciality Medicines Share Price Chart
Speciality Medicines Share Key Metrics
Volume
6000.00
Market Cap
136.09 CR
LTQ@LTP
1000@154.85
ATP
154.62
Var Margin
53.5 %
Circuit Range
139.45-170.35
Delivery %
100 %
Value
9.28 L
ASM/GSM
No
Market Lot
1000
Speciality Medicines Resistance and Support
Pivot 154.63
Resistance
First Resistance
155.26
Second Resistance
155.63
Third Resistance
156.26
Support
First Support
154.26
Second Support
153.63
Third Support
153.26
Speciality Medicines Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-28 | Audited Results |
Speciality Medicines News
Speciality Medicines Ltd - 544738 - Notice Of 5Th Annual General Meeting
Speciality Medicines announced the proposed re-appointment of Mr. Sumit Babubhai Goyani as Whole-Time Director. Mr. Goyani, a promoter and founder of the company, will serve for another five-year term, effective from June 01, 2024, subject to shareholder approval at the upcoming AGM.
Sep 03 2026 19:42:16
Speciality Medicines Ltd - 544738 - Board Meeting Outcome for Outcome Of Board Meeting Held On September 03, 2026
Speciality Medicines board approved its Director's Report and other reports for the Annual Report 2025-26. The 5th Annual General Meeting is scheduled for September 28, 2026, with NSDL appointed as the e-voting agency and a scrutinizer.
Sep 03 2026 15:50:56
Speciality Medicines Ltd - 544738 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Speciality Medicines Limited received regulatory approval for two new pharmaceutical formulations, Olanzapine Tablets 5 mg (Olazyn 5) and Diazepam Tablets 5 mg (Diazem 5), from the Ethiopian health authority. This expands the company's international product portfolio in the region.
Aug 12 2026 17:03:14
Speciality Medicines Management
| Name | Position |
|---|---|
| Anita Kumawat | Company Secretary & Compliance Officer |
| Chandresh M Unagar | Non Executive Independent Director |
Speciality Medicines Similar Stocks
Rama Vision Ltd.
169.95
0.40 (0.24%)
Kaira Can Company Ltd.
1490.00
0.00 (0.00%)
Gujjubhai Industries Ltd.
99.95
-0.50 (0.50%)
Abate AS Industries Ltd.
8.68
0.08 (0.93%)
Saptarishi Agro Industries Ltd.
25.50
0.00 (0.00%)
Super Tannery Ltd.
11.55
0.00 (0.00%)
Bhilwara Spinners Ltd.
133.00
0.00 (0.00%)
AG Ventures Ltd.
127.00
-1.80 (1.40%)
Speciality Medicines FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SPML
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC